臨床婦人科産科75巻8号

2021年08月発行

今月の臨床 エキスパートに聞く 耐性菌と院内感染―産婦人科医に必要な基礎知識

耐性菌各論―診断法と制御・治療戦略

多剤耐性緑膿菌・アシネトバクター（MDRP／MDRA）

著者： 山室亮介¹

所属機関： ¹虎の門病院臨床感染症科

ページ範囲：P.744 - P.751

文献概要

●MDRP，MDRAの定義は感染症法の規定と国外の定義で異なる．

●MDRPやMDRAが検出された場合，速やかに感染対策を実施し，治療対象とすべき原因菌か定着菌なのかを考える．

●MDRPやMDRAの国内における治療法は確立しておらず，必ず専門家とともに治療にあたる．

参考文献

1）厚生労働省院内感染対策サーベイランス事業　公開情報2019年1月〜12月年報（全集計対象医療機関）．院内感染対策サーベイランス検査部門【入院検体】．データ集計日：2020年4月6日，公開情報掲載日：2020年6月26日．https://janis.mhlw.go.jp/report/open_report/2019/3/1/ken_Open_Report_201900.pdf

2）Weiner LM, et al : Antimicrobial-resistant pathogens associated with healthcare-associated infections : summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2011-2014. Infect Control Hosp Epidemiol 37 : 1288-1301, 2016

3）De Oliveira DMP, et al : Antimicrobial resistance in ESKAPE pathogens. Clin Microbiol Rev 33 : e00181-19, 2020

4）Tamma PD, et al : Infectious Diseases Society of America Guidance on the Treatment of Extended-Spectrum beta-lactamase Producing Enterobacterales（ESBL-E）, Carbapenem-Resistant Enterobacterales（CRE）, and Pseudomonas aeruginosa with Difficult-to-Treat Resistance（DTR-P. aeruginosa）. Clin Infect Dis 72 : e169-e183, 2021

5）Valero C, et al : Acinetobacter bacteraemia in a teaching hospital, 1989-1998. Eur J Intern Med 12 : 425-429, 2001

6）Yang S, et al : Risk factors for mortality in Acinetobacter bacteremia. Braz J Infect Dis 15 : 501-502, 2011

7）Gaynes R, et al : Overview of nosocomial infections caused by gram-negative bacilli. Clin Infect Dis 41 : 848-854, 2005

8）El-Saed A, et al : Acinetobacter is the most common pathogen associated with late-onset and recurrent ventilator-associated pneumonia in an adult intensive care unit in Saudi Arabia. Int J Infect Dis 17 : e696-e701, 2013

9）Giammanco A, et al : Global assessment of the activity of tigecycline against multidrug-resistant gram-negative pathogens between 2004 and 2014 as part of the tigecycline evaluation and surveillance trial. mSphere 2 : e00310-e00316, 2017

10）Carbapenem-resistant Acinetobacter' fact sheet. CDC's 2019 antibiotic resistance threats report https://www.cdc.gov/drugresistance/pdf/threats-report/acinetobacter-508.pdf

11）Xie R, et al : Analysis of global prevalence of antibiotic resistance in Acinetobacter baumannii infections disclosed a faster increase in OECD countries. Emerg Microbes Infect 7 : 31, 2018

12）Nicolle LE, et al : Clinical practice guideline for the management of asymptomatic bacteriuria : 2019 update by the Infectious Diseases Society of America. Clin Infect Dis 68 : e83-e110, 2019

13）Seki M, et al : Nosocomial outbreak of multidrug-resistant Pseudomonas aeruginosa caused by damaged transesophageal echocardiogram probe used in cardiovascular surgical operations. J Infect Chemother 19 : 677-681, 2013

14）Berrouane YF, et al : Outbreak of severe Pseudomonas aeruginosa infections caused by a contaminated drain in a whirlpool bathtub. Clin Infect Dis 31 : 1331-1337, 2000

15）Wang CH, et al : Outbreak of imipenem-resistant Acinetobacter baumannii in different wards at a regional hospital related to untrained bedside caregivers. Am J Infect Control 45 : 1086-1090, 2017

16）Nouer SA, et al : Risk factors for acquisition of multidrug-resistant Pseudomonas aeruginosa producing SPM metallo-beta-lactamase. Antimicrob Agents Chemother 49 : 3663-3667, 2005

17）Lim CLL, et al : Importance of control groups when delineating antibiotic use as a risk factor for carbapenem resistance, extreme-drug resistance, and pan-drug resistance in Acinetobacter baumannii and Pseudomonas aeruginosa : A systematic review and meta-analysis. Int J Infect Dis 76 : 48-57, 2018